Columbus Memory Center

Columbus, Georgia 31909

1 studies enrolling now · 10 studies all time

What they study most

Alzheimer Disease, Alzheimer Disease Due to P. Gingivalis, Alzheimer's Disease, Early Alzheimer's Disease, Early Preclinical Alzheimer's Disease, Mild to Moderate Alzheimer's Disease, Preclinical Alzheimer's Disease

Studies at this site

• Study of LHP588 in Subjects With P. Gingivalis-Positive Alzheimer's Disease — Recruiting now
• Long-term Extension of Phase 3 Study of ALZ- 801 in APOE4/4 Early AD Subjects — Stopped early
• AHEAD 3-45 Study: A Study to Evaluate Efficacy and Safety of Treatment With Lecanemab in Participants With Preclinical Alzheimer's Disease and Elevated Amyloid and Also in Participants With Early Preclinical Alzheimer's Disease and Intermediate Amyloid — Running, not enrolling
• A Study to Confirm Safety and Efficacy of Lecanemab in Participants With Early Alzheimer's Disease — Running, not enrolling
• An Efficacy and Safety Study of ALZ-801 in APOE4/4 Early AD Subjects — Completed
• A Study to Evaluate Efficacy and Safety of Intravenous Sabirnetug in Participants With Early Alzheimer's Disease (ALTITUDE-AD) — Running, not enrolling
• Bryostatin Treatment of Moderately Severe Alzheimer's Disease — Completed
• Efficacy and Safety Study of Gantenerumab in Participants With Early Alzheimer's Disease (AD) — Stopped early
• Testing the Safety and Preliminary Efficacy of the New Drug ORY-2001 in Mild to Moderate Alzheimer's Disease — Completed
• A Study of Crenezumab Versus Placebo to Evaluate the Efficacy and Safety in Participants With Prodromal to Mild Alzheimer's Disease (AD) — Stopped early